Article open access publication

Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study

European Journal Of Haematology, Wiley, ISSN 1600-0609

Volume 97, 3, 2016

DOI:10.1111/ejh.12728, Dimensions: pub.1020865273, PMID: 26710662,

Affiliations

Organisations

  1. (1) University of Copenhagen, grid.5254.6, KU
  2. (2) Rigshospitalet Department of Hematology Copenhagen Denmark
  3. (3) Herlev Hospital, grid.411900.d, Capital Region
  4. (4) Odense University Hospital, grid.7143.1, Southern Denmark Region
  5. (5) Aalborg Hospital, grid.27530.33, North Denmark Region
  6. (6) Roskilde Hospital, grid.416059.f, Zealand Region
  7. (7) Aarhus University Hospital, grid.154185.c, Central Denmark Region
  8. (8) Vejle Sygehus, grid.417271.6, Southern Denmark Region
  9. (9) Regional Hospital Holstebro, grid.414304.6, Central Denmark Region
  10. (10) Hospital of South West Jutland, grid.414576.5, Southern Denmark Region

Countries

Denmark

Continents

Europe

Description

Several risk scores for disease progression in patients with smoldering multiple myeloma (SMM) have been proposed; however, all have been developed using single-center registries. To examine risk factors for time to progression (TTP) to multiple myeloma (MM) for SMM, we analyzed a nationwide population-based cohort of 321 patients with newly diagnosed SMM registered within the Danish Multiple Myeloma Registry between 2005 and 2014. Significant univariable risk factors for TTP were selected for multivariable Cox regression analyses. We found that both an M-protein ≥30 g/L and immunoparesis significantly influenced TTP (HR 2.7, 95%CI (1.5;4.7), P = 0.001, and HR 3.3, 95%CI (1.4;7.8), P = 0.002, respectively). High free light chain (FLC) ratio did not significantly influence TTP in our cohort. Therefore, our data do not support recent IMWG proposal of identifying patients with FLC ratio above 100 as having ultra high-risk of transformation to MM. Using only immunoparesis and M-protein ≥30 g/L, we created a scoring system to identify low-, intermediate-, and high-risk SMM. This first population-based study of patients with SMM confirms that an M-protein ≥30 g/L and immunoparesis remain important risk factors for progression to MM.

Research Categories

Main Subject Area

Fields of Research

Links & Metrics

NORA University Profiles

University of Copenhagen

Aalborg University

Dimensions Citation Indicators

Times Cited: 31

Field Citation Ratio (FCR): 10.05

Relative Citation ratio (RCR): 2.38

Open Access Info

Green, Published